01 1Cadila Pharmaceuticals
01 1SILDENAFIL CITRATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-23
Pay. Date : 2013-04-09
DMF Number : 21154
Submission : 2007-12-13
Status : Active
Type : II
20
Cadila Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SILDENAFIL CITRATE USP, with a corresponding US DMF Number 21154.
Remarkably, this DMF maintains an Active status since its submission on December 13, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 23, 2013, and payment made on April 09, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
